USD10
DWTX Shares
About Dogwood TherapeuticsDogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.
USD10
DWTX Shares
About Dogwood TherapeuticsDogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$55.15M
OPEN PRICE
$1.54
LOW (1Y)
$1.28
HIGH (1Y)
$9.50
LOW (24H)
$1.50
HIGH (24H)
$1.64
VOLUME (24H)
$48.65K
479.13%
Price history
Time | Price | Change |
|---|---|---|
Today | $1.54 | |
1 Day | $1.51 | |
1 Week | $1.52 | |
1 Month | $1.59 | |
1 Year | Not enough data | Not enough data |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.